Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea Source: Eur Respir J 2009; 34: 1390-1398 Year: 2009
Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Plasma endothelin-1 (ET-1) levels in obstructive sleep apnea (OSA) patients and effect of continouous positive airway pressure (CPAP) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
TGF-β1 type II receptor (TGF-βRII) expression in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 96s Year: 2005
Relationship between obstructive sleep apnoea syndrome (OSAS) and the levels of endothelial progenitor cells (EPC) in patients with acute stroke Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms Source: Eur Respir J 2001; 17: 728-732 Year: 2001
Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
Expression of bradykinin B2 receptor (B2R) and vascular endothelial growth factor (VEGF) in asthma and COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
Overexpression of angiotensin II type 1 receptor (AGTR1) and lymphatic vasculature rarefaction is present in scleroderma with pulmonary compromised Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels. Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Association of IL-6 and TNFα and leptin receptor (LEPR) gene polymorphism with IL-6 and TNFα serum level in obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
The role of endothelial dysfunction and oxidative stress in the pathogenesis of erectile dysfunction (ED) in obstructive sleep apnoea-hypopnoea syndrome (OSAHS) patients Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14 Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013
Endothelin receptor antagonist (ETRA) bosentan (B) in patients with severe pulmonary hypertension (PH) associated with pulmonary disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms Source: Eur Respir J 2001; 18: 1077 Year: 2001
Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004